Detalhe da pesquisa
1.
Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.
J Virol
; 97(8): e0078123, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565748
2.
CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rß-dependent EMT-like process.
BMC Cancer
; 19(1): 62, 2019 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642298
3.
APOBEC3 mutagenesis drives therapy resistance in breast cancer.
bioRxiv
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746158
4.
Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism.
bioRxiv
; 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778493
5.
Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
Cells
; 12(8)2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190094
6.
Acute expression of human APOBEC3B in mice results in RNA editing and lethality.
Genome Biol
; 24(1): 267, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001542
7.
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
Nat Genet
; 55(10): 1721-1734, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735199
8.
Tribbles Pseudokinase 3 Regulation and Contribution to Cancer.
Cancers (Basel)
; 13(8)2021 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33920424
9.
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma.
Cancers (Basel)
; 13(22)2021 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831022
10.
The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.
Cancer Res
; 80(15): 3062-3069, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245795
11.
Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing.
Cancer Res
; 80(11): 2190-2203, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245792
12.
MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma.
Sci Rep
; 9(1): 12301, 2019 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444479